AAAAAA

   
Results: 1-10 |
Results: 10
Effects of oral vitamin K on S- and R-Warfarin pharmacokinetics and pharmacodynamics: Enhanced safety of warfarin as a CYP2C9 probe
Authors: Kim, JS Nafziger, AN Gaedigk, A Dickmann, LJ Rettie, AE Bertino, JS
Citation: Js. Kim et al., Effects of oral vitamin K on S- and R-Warfarin pharmacokinetics and pharmacodynamics: Enhanced safety of warfarin as a CYP2C9 probe, J CLIN PHAR, 41(7), 2001, pp. 715-722
Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations
Authors: Gaedigk, A Casley, WL Tyndale, RF Sellers, EM Jurima-Romet, M Leeder, JS
Citation: A. Gaedigk et al., Cytochrome P4502C9 (CYP2C9) allele frequencies in canadian native indian and inuit populations, CAN J PHYSL, 79(10), 2001, pp. 841-847
Localization of N-acetyltransferases NAT1 and NAT2 in human tissues
Authors: Windmill, KF Gaedigk, A Hall, PDM Samaratunga, H Grant, DM McManus, ME
Citation: Kf. Windmill et al., Localization of N-acetyltransferases NAT1 and NAT2 in human tissues, TOXICOL SCI, 54(1), 2000, pp. 19-29
Interethnic differences of drug-metabolizing enzymes
Authors: Gaedigk, A
Citation: A. Gaedigk, Interethnic differences of drug-metabolizing enzymes, INT J CL PH, 38(2), 2000, pp. 61-68
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"
Authors: Streetman, DS Bleakley, JF Kim, JS Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS
Citation: Ds. Streetman et al., Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail", CLIN PHARM, 68(4), 2000, pp. 375-383
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
Authors: Gaedigk, A Gotschall, RR Forbes, NS Simon, SD Kearns, GL Leeder, JS
Citation: A. Gaedigk et al., Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data, PHARMACOGEN, 9(6), 1999, pp. 669-682
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity
Authors: Kashuba, ADM Nafziger, AN Kearns, GL Leeder, JS Gotschall, R Gaedigk, A Bertino, JS
Citation: Adm. Kashuba et al., Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity, PHARMACOGEN, 9(4), 1999, pp. 453-462
Structural characterization of human aryl sulphotransferases
Authors: Brix, LA Duggleby, RG Gaedigk, A McManus, ME
Citation: La. Brix et al., Structural characterization of human aryl sulphotransferases, BIOCHEM J, 337, 1999, pp. 337-343
Crystal structure of human catecholamine sulfotransferase
Authors: Bidwell, LM McManus, ME Gaedigk, A Kakuta, Y Negishi, M Pedersen, L Martin, JL
Citation: Lm. Bidwell et al., Crystal structure of human catecholamine sulfotransferase, J MOL BIOL, 293(3), 1999, pp. 521-530
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping
Authors: Streetman, DS Ellis, RE Nafziger, AN Leeder, JS Gaedigk, A Gotschall, R Kearns, GL Bertino, JS
Citation: Ds. Streetman et al., Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping, CLIN PHARM, 66(5), 1999, pp. 535-541
Risultati: 1-10 |